Boosting your Brain:Cognitive Enhancement and Neuroethics
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Dr Nigel Bennee.
Cognitive enhancing drugs are needed to treat the cognitive impairments associated with debilitating neuropsychiatric disorders, such as Alzheimer’s disease, schizophrenia and attention deficit hyperactivity disorder. Such treatments will improve the quality of life and wellbeing for patients and their families and reduce the financial burden on society.
Cognitive enhancement is of great interest to the general public and has implications for society, particularly in regard to the increasing use of cognitive enhancing drugs in school age children, and in young adults and academic staff at university. Therefore, it is important to consider the potential harms of these drugs, for example substance abuse, unknown effects on the developing brain or coercion at school or work. Nevertheless, with the rapidly developing field of pharmacogenomics we may be able to gain maximum benefits with minimum harms to the individual and society as a whole. Certainly, the benefits of safe and effective cognitive enhancing drugs to society, including the ageing population and people with neuropsychiatric disorders and brain injury, are great.
This talk is part of the Cambridge Society for the Application of Research (CSAR) series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|
![[Search]](http://talks.cam.ac.uk/images/search.gif?1209136071)
|![[A-Z Index]](http://talks.cam.ac.uk/images/az.gif?1209136071)
|![[Contact]](http://talks.cam.ac.uk/images/contact.gif?1209136071)
![[University of Cambridge]](http://talks.cam.ac.uk/images/identifier2.gif?1209136071){kind=small}
![[Talks.cam]](http://talks.cam.ac.uk/images/talkslogosmall.gif?1209136071)
Professor Barbara Sahakian, Department of Psychiatry, School of Clinical Medicine, University of Cambridge
Monday 06 February 2012, 19:30-21:00